Eurofins Scientific SE

Equities

ERF

FR0014000MR3

Healthcare Facilities & Services

Real-time Euronext Paris 10:02:49 2024-04-16 am EDT 5-day change 1st Jan Change
59.04 EUR -2.57% Intraday chart for Eurofins Scientific SE -2.41% +0.07%

This article is reserved for members

Already a member?

Log In

Not a member ?

Free registration
CAC40: week ends at half-mast, gold at its zenith CF
CAC40: pullback reduced, WStreet +0.7%, Brent at $91, Gold at $233 CF
CAC40: easily preserves 8,000Pts, NFP has no impact CF
CAC40: ends the day balanced after a salvo of statistics CF
CAC40: frozen at 8,155, W-Street well disposed, gold at its zenith CF
CAC40: indecisive towards 8,160, W-Street climbs back to the top CF
EUROFINS SCIENTIFIC : Berenberg raises its price target CF
CAC40: up slightly after PMI figures CF
Eurofins Scientific to Purchase US-based Ascend Clinical MT
Eurofins completes acquisition of Ascend Clinical CF
Eurofins Scientific SE acquired Ascend Clinical, LLC. CI
CAC40: ends with a balanced performance, helped by the banking sector CF
CAC40: all-time high, tackles 8250 resistance level CF
European Equities Close Mixed in Monday Trading; Real Estate, Pharmaceutical Stocks Rise MT
CAC40: insignificant decline in limited volumes CF
Enzymatica Obtains CE Marking for ColdZyme Mouth Spray MT
CAC40: zero reaction to US PCE, but February ends on a high note CF
CAC40: steady ahead of US inflation figures CF
CAC40: frozen at 7.945, heavy sanction on Teleperformance CF
CAC40: remains stable despite Teleperformance's fall CF
EUROFINS SCIENTIFIC : Lackluster FCF and dividend cut weigh on the share price Alphavalue
CAC40: up slightly, driven by Bouygues and Alstom CF
CAC40: approaches 8,000, Nasdaq solid despite US stats CF
CAC40: back above 7,950, tech supports Wall-Street CF
Transcript : Eurofins Scientific SE, 2023 Earnings Call, Feb 27, 2024
Chart Eurofins Scientific SE
More charts
Eurofins Scientific SE is one of the world's leading providers of bio-analytical services. The group's services are intended to validate the safety, authenticity, origin, identity, and purity of biological substances contained in the environment (water, air, soil, etc.) and in food, pharmaceutical, cosmetic, and hygiene products. At the end of 2023, Eurofins Scientific SE owned a portfolio of over 200,000 analytical methods and had 900 laboratories located throughout the world. Net sales are distributed geographically as follows: Europe (50.7%), North America (38.5%) and other (10.8%).
More about the company
Trading Rating
Investor Rating
ESG Refinitiv
A-
More Ratings
Sell
Consensus
Buy
Mean consensus
HOLD
Number of Analysts
16
Last Close Price
60.6 EUR
Average target price
59.28 EUR
Spread / Average Target
-2.18%
Consensus

Quarterly revenue - Rate of surprise

  1. Stock Market
  2. Equities
  3. ERF Stock
  4. News Eurofins Scientific SE
  5. Eurofins Scientific : Launches New Test, Increased Capacity to Detect SARS-CoV-2 Variants